A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality

Autores
Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; Zhang, Chengyue; Zhao, Junyang; Wilson, Matthew W.; Kim, Jonathan; Khetan, Vikas; Ganesan, Suganeswari; Yarovoy, Andrey; Yarovaya, Vera; Kotova, Elena; Yousef, Yacoub A.; Nummi, Kalle; Ushakova, Tatiana L.; Yugay, Olga V.; Polyakov, Vladimir G.; Ramirez Ortiz, Marco A.; Esparza Aguiar, Elizabeth; Chantada, Guillermo Luis; Schaiquevich, Paula Susana; Fandino, Adriana; Yam, Jason C.; Lau, Winnie W.; Lam, Carol P.; Sharwood, Phillipa; Moorthy, Sonia; Long, Quah Boon
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB.
Fil: Tomar, Ankit Singh. The New York Eye Cancer Center; Estados Unidos
Fil: Finger, Paul T.. The New York Eye Cancer Center; Estados Unidos
Fil: Gallie, Brenda. The Eye Cancer Clinic, Princess Margaret Cancer Centre; Canadá
Fil: Mallipatna, Ashwin. Hospital for Sick Children; Canadá
Fil: Kivelä, Tero T.. Helsinki University Hospital; Finlandia
Fil: Zhang, Chengyue. Beijing Children's Hospital; China
Fil: Zhao, Junyang. Beijing Children's Hospital; China
Fil: Wilson, Matthew W.. University of Tennessee; Estados Unidos
Fil: Kim, Jonathan. University of Southern California; Estados Unidos
Fil: Khetan, Vikas. Sankara Nethralaya; India
Fil: Ganesan, Suganeswari. Sankara Nethralaya; India
Fil: Yarovoy, Andrey. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Yarovaya, Vera. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Kotova, Elena. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Yousef, Yacoub A.. King Hussein Cancer Center; Jordania
Fil: Nummi, Kalle. University of Helsinki; Finlandia
Fil: Ushakova, Tatiana L.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Yugay, Olga V.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Polyakov, Vladimir G.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Ramirez Ortiz, Marco A.. Hospital Infantil de México Federico Gómez; México
Fil: Esparza Aguiar, Elizabeth. Hospital Infantil de México Federico Gómez; México
Fil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Fandino, Adriana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Yam, Jason C.. The Chinese University of Hong Kong; Hong Kong
Fil: Lau, Winnie W.. The Chinese University of Hong Kong; Hong Kong
Fil: Lam, Carol P.. The Chinese University of Hong Kong; Hong Kong
Fil: Sharwood, Phillipa. University of Sydney; Australia
Fil: Moorthy, Sonia. KK Women's and Children's Hospital; Singapur
Fil: Long, Quah Boon. KK Women's and Children's Hospital; Singapur
Materia
RETINOBLASTOMA
METASTASIS
STAGING SYSTEM
TNM
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/156304

id CONICETDig_700c0838eb44f1b906395f3f7667f349
oai_identifier_str oai:ri.conicet.gov.ar:11336/156304
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated MortalityTomar, Ankit SinghFinger, Paul T.Gallie, BrendaMallipatna, AshwinKivelä, Tero T.Zhang, ChengyueZhao, JunyangWilson, Matthew W.Kim, JonathanKhetan, VikasGanesan, SuganeswariYarovoy, AndreyYarovaya, VeraKotova, ElenaYousef, Yacoub A.Nummi, KalleUshakova, Tatiana L.Yugay, Olga V.Polyakov, Vladimir G.Ramirez Ortiz, Marco A.Esparza Aguiar, ElizabethChantada, Guillermo LuisSchaiquevich, Paula SusanaFandino, AdrianaYam, Jason C.Lau, Winnie W.Lam, Carol P.Sharwood, PhillipaMoorthy, SoniaLong, Quah BoonRETINOBLASTOMAMETASTASISSTAGING SYSTEMTNMhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB.Fil: Tomar, Ankit Singh. The New York Eye Cancer Center; Estados UnidosFil: Finger, Paul T.. The New York Eye Cancer Center; Estados UnidosFil: Gallie, Brenda. The Eye Cancer Clinic, Princess Margaret Cancer Centre; CanadáFil: Mallipatna, Ashwin. Hospital for Sick Children; CanadáFil: Kivelä, Tero T.. Helsinki University Hospital; FinlandiaFil: Zhang, Chengyue. Beijing Children's Hospital; ChinaFil: Zhao, Junyang. Beijing Children's Hospital; ChinaFil: Wilson, Matthew W.. University of Tennessee; Estados UnidosFil: Kim, Jonathan. University of Southern California; Estados UnidosFil: Khetan, Vikas. Sankara Nethralaya; IndiaFil: Ganesan, Suganeswari. Sankara Nethralaya; IndiaFil: Yarovoy, Andrey. Fyodorov Eye Microsurgery Federal State Institution; RusiaFil: Yarovaya, Vera. Fyodorov Eye Microsurgery Federal State Institution; RusiaFil: Kotova, Elena. Fyodorov Eye Microsurgery Federal State Institution; RusiaFil: Yousef, Yacoub A.. King Hussein Cancer Center; JordaniaFil: Nummi, Kalle. University of Helsinki; FinlandiaFil: Ushakova, Tatiana L.. Blokhin National Medical Research Center Oncology of Russian Federation; RusiaFil: Yugay, Olga V.. Blokhin National Medical Research Center Oncology of Russian Federation; RusiaFil: Polyakov, Vladimir G.. Blokhin National Medical Research Center Oncology of Russian Federation; RusiaFil: Ramirez Ortiz, Marco A.. Hospital Infantil de México Federico Gómez; MéxicoFil: Esparza Aguiar, Elizabeth. Hospital Infantil de México Federico Gómez; MéxicoFil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Fandino, Adriana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Yam, Jason C.. The Chinese University of Hong Kong; Hong KongFil: Lau, Winnie W.. The Chinese University of Hong Kong; Hong KongFil: Lam, Carol P.. The Chinese University of Hong Kong; Hong KongFil: Sharwood, Phillipa. University of Sydney; AustraliaFil: Moorthy, Sonia. KK Women's and Children's Hospital; SingapurFil: Long, Quah Boon. KK Women's and Children's Hospital; SingapurElsevier Science Inc.2020-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/156304Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; et al.; A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality; Elsevier Science Inc.; Ophthalmology; 127; 12; 6-2020; 1719-17320161-64201549-4713CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.aaojournal.org/article/S0161-6420(20)30516-9/fulltextinfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2020.05.050info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:16:40Zoai:ri.conicet.gov.ar:11336/156304instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:16:41.236CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
title A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
spellingShingle A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
Tomar, Ankit Singh
RETINOBLASTOMA
METASTASIS
STAGING SYSTEM
TNM
title_short A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
title_full A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
title_fullStr A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
title_full_unstemmed A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
title_sort A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
dc.creator.none.fl_str_mv Tomar, Ankit Singh
Finger, Paul T.
Gallie, Brenda
Mallipatna, Ashwin
Kivelä, Tero T.
Zhang, Chengyue
Zhao, Junyang
Wilson, Matthew W.
Kim, Jonathan
Khetan, Vikas
Ganesan, Suganeswari
Yarovoy, Andrey
Yarovaya, Vera
Kotova, Elena
Yousef, Yacoub A.
Nummi, Kalle
Ushakova, Tatiana L.
Yugay, Olga V.
Polyakov, Vladimir G.
Ramirez Ortiz, Marco A.
Esparza Aguiar, Elizabeth
Chantada, Guillermo Luis
Schaiquevich, Paula Susana
Fandino, Adriana
Yam, Jason C.
Lau, Winnie W.
Lam, Carol P.
Sharwood, Phillipa
Moorthy, Sonia
Long, Quah Boon
author Tomar, Ankit Singh
author_facet Tomar, Ankit Singh
Finger, Paul T.
Gallie, Brenda
Mallipatna, Ashwin
Kivelä, Tero T.
Zhang, Chengyue
Zhao, Junyang
Wilson, Matthew W.
Kim, Jonathan
Khetan, Vikas
Ganesan, Suganeswari
Yarovoy, Andrey
Yarovaya, Vera
Kotova, Elena
Yousef, Yacoub A.
Nummi, Kalle
Ushakova, Tatiana L.
Yugay, Olga V.
Polyakov, Vladimir G.
Ramirez Ortiz, Marco A.
Esparza Aguiar, Elizabeth
Chantada, Guillermo Luis
Schaiquevich, Paula Susana
Fandino, Adriana
Yam, Jason C.
Lau, Winnie W.
Lam, Carol P.
Sharwood, Phillipa
Moorthy, Sonia
Long, Quah Boon
author_role author
author2 Finger, Paul T.
Gallie, Brenda
Mallipatna, Ashwin
Kivelä, Tero T.
Zhang, Chengyue
Zhao, Junyang
Wilson, Matthew W.
Kim, Jonathan
Khetan, Vikas
Ganesan, Suganeswari
Yarovoy, Andrey
Yarovaya, Vera
Kotova, Elena
Yousef, Yacoub A.
Nummi, Kalle
Ushakova, Tatiana L.
Yugay, Olga V.
Polyakov, Vladimir G.
Ramirez Ortiz, Marco A.
Esparza Aguiar, Elizabeth
Chantada, Guillermo Luis
Schaiquevich, Paula Susana
Fandino, Adriana
Yam, Jason C.
Lau, Winnie W.
Lam, Carol P.
Sharwood, Phillipa
Moorthy, Sonia
Long, Quah Boon
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv RETINOBLASTOMA
METASTASIS
STAGING SYSTEM
TNM
topic RETINOBLASTOMA
METASTASIS
STAGING SYSTEM
TNM
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB.
Fil: Tomar, Ankit Singh. The New York Eye Cancer Center; Estados Unidos
Fil: Finger, Paul T.. The New York Eye Cancer Center; Estados Unidos
Fil: Gallie, Brenda. The Eye Cancer Clinic, Princess Margaret Cancer Centre; Canadá
Fil: Mallipatna, Ashwin. Hospital for Sick Children; Canadá
Fil: Kivelä, Tero T.. Helsinki University Hospital; Finlandia
Fil: Zhang, Chengyue. Beijing Children's Hospital; China
Fil: Zhao, Junyang. Beijing Children's Hospital; China
Fil: Wilson, Matthew W.. University of Tennessee; Estados Unidos
Fil: Kim, Jonathan. University of Southern California; Estados Unidos
Fil: Khetan, Vikas. Sankara Nethralaya; India
Fil: Ganesan, Suganeswari. Sankara Nethralaya; India
Fil: Yarovoy, Andrey. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Yarovaya, Vera. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Kotova, Elena. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Yousef, Yacoub A.. King Hussein Cancer Center; Jordania
Fil: Nummi, Kalle. University of Helsinki; Finlandia
Fil: Ushakova, Tatiana L.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Yugay, Olga V.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Polyakov, Vladimir G.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Ramirez Ortiz, Marco A.. Hospital Infantil de México Federico Gómez; México
Fil: Esparza Aguiar, Elizabeth. Hospital Infantil de México Federico Gómez; México
Fil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Fandino, Adriana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Yam, Jason C.. The Chinese University of Hong Kong; Hong Kong
Fil: Lau, Winnie W.. The Chinese University of Hong Kong; Hong Kong
Fil: Lam, Carol P.. The Chinese University of Hong Kong; Hong Kong
Fil: Sharwood, Phillipa. University of Sydney; Australia
Fil: Moorthy, Sonia. KK Women's and Children's Hospital; Singapur
Fil: Long, Quah Boon. KK Women's and Children's Hospital; Singapur
description Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB.
publishDate 2020
dc.date.none.fl_str_mv 2020-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/156304
Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; et al.; A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality; Elsevier Science Inc.; Ophthalmology; 127; 12; 6-2020; 1719-1732
0161-6420
1549-4713
CONICET Digital
CONICET
url http://hdl.handle.net/11336/156304
identifier_str_mv Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; et al.; A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality; Elsevier Science Inc.; Ophthalmology; 127; 12; 6-2020; 1719-1732
0161-6420
1549-4713
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.aaojournal.org/article/S0161-6420(20)30516-9/fulltext
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2020.05.050
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Science Inc.
publisher.none.fl_str_mv Elsevier Science Inc.
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614113656832000
score 13.070432